Streetbeat News

Products Services

MAMA

Mama's Creations has launched its first-ever direct-to-consumer e-commerce platform, expanding its business model to include online sales and reinforcing its strategy to serve as a one-stop-shop for both retailers and consumers.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:33 pm

BMRN

EWG

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has reached an agreement with the German National Association of Statutory Health Insurance Funds on the reimbursement for ROCTAVIAN, a gene therapy for severe hemophilia A. This marks the first gene therapy for hemophilia with an approved federal price in Germany. The therapy is priced at €28,933.53 per vial, approximately $900,000 per patient. The agreement includes an outcome-based model tied to real-world data and has a minimum term of 3 years. Two patients in Germany have received ROCTAVIAN, and 60 are eligible for treatment. BioMarin is also negotiating the final price with the Italian Medicines Agency and is working with U.S. payers to increase access to ROCTAVIAN.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:31 pm

EVAX

Evaxion Biotech has announced the successful design of precision cancer vaccines for hematological cancers using its AI-Immunology platform. The vaccines target a new class of antigens and have broad applicability for treating hematological malignancies, promising significant benefits for patients.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:28 pm

CVGW

PLAG

SPB

UPXI

XXII

The article highlights five consumer staples stocks considered oversold based on their Relative Strength Index (RSI) values, suggesting they may be undervalued. Spectrum Brands Holdings (SPB) reported a slight sales decline but is increasing marketing investments. Planet Green Holdings (PLAG) saw a significant stock price drop over the past month. Upexi (UPXI) reported a larger-than-expected quarterly loss but showed revenue growth. Calavo Growers (CVGW) posted strong earnings with a focus on avocado margins. 22nd Century Group (XXII) is selling most of its Hemp/Cannabis operations. All companies have RSI values near or below 30, indicating potential for short-term performance improvement.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 1:27 pm

ENSC

Ensysce Biosciences, Inc. (ENSC) and OncoZenge AB have signed a letter of intent for the co-development of BupiZenge™ in the U.S. BupiZenge™ is a non-opioid treatment for oral mucositis pain, a condition caused by cancer treatments. The collaboration aims to accelerate the commercialization of BupiZenge™ in the U.S. market, leveraging both companies' expertise. OncoZenge has completed Phase 2 trials in the EU, with plans for Phase 3. The partnership is expected to enhance patient care in analgesia and oncology by providing a new treatment option.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:25 pm

SLGL

Sol-Gel Technologies Ltd (NASDAQ:SLGL) announced a virtual KOL event on December 6, 2023, to discuss Gorlin Syndrome and the Phase 3 trial for SGT-610, a potential treatment. SGT-610 has received Orphan Drug and Breakthrough Designations from the FDA. The event will feature discussions on the disease burden, SGT-610's therapeutic potential, and market insights. Julie Breneiser from the Gorlin Syndrome Alliance and Dr. Ervin Epstein Jr., a dermatologist and co-founder of PellePharm Inc., will speak at the event.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:21 pm

G

Genpact (NYSE:G), a global professional services firm, has released an industry-first playbook for scaling responsible generative AI projects, called FMOps – The Generative AI Imperative for Production. Developed with Nasscom, it provides guidelines for transitioning from pilot to production generative AI projects, focusing on Foundation Model Operations (FMOps) and including Large Language Model Operations (LLMOps) and Machine Learning Operations (MLOps). The playbook emphasizes the need for ethical and scalable solutions, improved collaboration, faster release cycles, and risk reduction in AI systems.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:21 pm

TWKS

Thoughtworks (NASDAQ:TWKS), a global technology consultancy, announced its expansion into Switzerland as part of its strategy to scale up in key European industry verticals. The company, which serves financial and health services clients, aims to grow its market presence in Europe and provide enhanced service to its Swiss clients, including SMG Swiss Marketplace Group and V-Zug.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:18 pm

ARE

LLY

Alexandria Real Estate Equities, Inc. (ARE) has announced an exclusive partnership with Eli Lilly and Company (LLY) to expand Lilly Gateway Labs to San Diego, aiming to accelerate the development of early-stage life science companies. The new site will be located in Alexandria's University Town Center submarket, providing emerging biotech companies with laboratories, collaboration opportunities with Lilly, and access to capital. This initiative builds on the strategic relationship between ARE and LLY since 2008 and leverages San Diego's thriving life science ecosystem. The Gateway Labs San Diego site is expected to open in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:16 pm

SNAX

Stryve Foods, a company specializing in air-dried meat snacks, has announced a significant expansion of its distribution network. The company's products will now be available in several leading retailers across the United States, which is expected to increase the brand's visibility and accessibility to consumers. This expansion could potentially lead to increased sales and revenue for Stryve Foods.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:15 pm